-
The authors randomized women with objectively validated heavy menstrual bleeding (mean menstrual blood loss [MBL] of 80 mL or more per cycle, confirmed using the alkaline hematin methodology during two pretreatment cycles) to treatment with oral tranexamic acid 3.9 g/d or placebo for up to 5 days per cycle for 6 menstrual cycles.
-
Nearly every reference source discussing the primary management of advanced ovarian cancer will highlight the role of surgical cytoreduction as an important first step in the care of this disease.
-
-
More women are taking a second look at the intrauterine device (IUD) for contraception. IUD insertions went up 23% between January 2008 and January 2009, according to SDI Health, a health care analytics firm in Plymouth Meeting, PA.
-
Where do male services fit in the picture when it comes to your facility? While most family planning centers report a percentage of male patients who receive sexually transmitted infection care (74%) and contraceptive care (68%), males make up only 5% nationally of their overall caseload.
-
As a reproductive health clinician, you might be looking to upcoming health care reform to make a difference in improving the status of sexual health care in the United States.
-
Results of a recent analysis of a survey of HIV care providers shows that clinicians often don't screen for genital herpes (herpes simplex virus-2 or HSV-2) in HIV-positive patients.
-
-
Be sure to include questions on alcohol consumption during adolescent screenings. Why? Results of a new analysis of national data from the Centers for Disease Control and Prevention (CDC) show that more than one in four U.S. teens and young adults admit they are binge drinkers.
-
A Guttmacher Institute analysis of new U.S. Census Bureau data reveals the number of U.S. women ages 15-44 covered by private insurance dropped between 2008 and 2009, as widespread job losses resulted in many Americans losing their employer-based insurance.
